These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29273204)

  • 1. Locking the Elbow: Improved Antibody Fab Fragments as Chaperones for Structure Determination.
    Bailey LJ; Sheehy KM; Dominik PK; Liang WG; Rui H; Clark M; Jaskolowski M; Kim Y; Deneka D; Tang WJ; Kossiakoff AA
    J Mol Biol; 2018 Feb; 430(3):337-347. PubMed ID: 29273204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered antigen-binding fragments for enhanced crystallization of antibody:antigen complexes.
    Bruce HA; Singer AU; Filippova EV; Blazer LL; Adams JJ; Enderle L; Ben-David M; Radley EH; Mao DYL; Pau V; Orlicky S; Sicheri F; Kurinov I; Atwell S; Kossiakoff AA; Sidhu SS
    Protein Sci; 2024 Jan; 33(1):e4824. PubMed ID: 37945533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fab Chaperone-Assisted RNA Crystallography (Fab CARC).
    Sherman E; Archer J; Ye JD
    Methods Mol Biol; 2016; 1320():77-109. PubMed ID: 26227039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A portable RNA sequence whose recognition by a synthetic antibody facilitates structural determination.
    Koldobskaya Y; Duguid EM; Shechner DM; Suslov NB; Ye J; Sidhu SS; Bartel DP; Koide S; Kossiakoff AA; Piccirilli JA
    Nat Struct Mol Biol; 2011 Jan; 18(1):100-6. PubMed ID: 21151117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a universal nanobody-binding Fab module for fiducial-assisted cryo-EM studies of membrane proteins.
    Bloch JS; Mukherjee S; Kowal J; Filippova EV; Niederer M; Pardon E; Steyaert J; Kossiakoff AA; Locher KP
    Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34782475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-binding fragments with improved crystal lattice packing and enhanced conformational flexibility at the elbow region as crystallization chaperones.
    Bruce HA; Singer AU; Blazer LL; Luu K; Ploder L; Pavlenco A; Kurinov I; Adams JJ; Sidhu SS
    Protein Sci; 2024 Jul; 33(7):e5081. PubMed ID: 38924648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Fab presentation on phage surface with the use of molecular chaperone coplasmid system.
    Loh Q; Leong SW; Tye GJ; Choong YS; Lim TS
    Anal Biochem; 2015 May; 477():56-61. PubMed ID: 25769419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Basis of Enhanced Crystallizability Induced by a Molecular Chaperone for Antibody Antigen-Binding Fragments.
    Ereño-Orbea J; Sicard T; Cui H; Carson J; Hermans P; Julien JP
    J Mol Biol; 2018 Feb; 430(3):322-336. PubMed ID: 29277294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal Structure of a Bivalent Antibody Fab Fragment.
    Shahid S; Gao M; Travis Gallagher D; Pozharski E; Brinson RG; Keck ZY; Foung SKH; Fuerst TR; Mariuzza RA
    J Mol Biol; 2021 Jan; 433(2):166714. PubMed ID: 33220264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and biophysical characterization of an epitope-specific engineered Fab fragment and complexation with membrane proteins: implications for co-crystallization.
    Johnson JL; Entzminger KC; Hyun J; Kalyoncu S; Heaner DP; Morales IA; Sheppard A; Gumbart JC; Maynard JA; Lieberman RL
    Acta Crystallogr D Biol Crystallogr; 2015 Apr; 71(Pt 4):896-906. PubMed ID: 25849400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of phase plate cryo-EM reveals conformation diversity of therapeutic IgG with 50 kDa Fab fragment resolved below 6 Å.
    Lin HH; Wang CH; Huang SH; Lin SY; Kato T; Namba K; Hosogi N; Song C; Murata K; Yen CH; Hsu TL; Wong CH; Wu YM; Tu IP; Chang WH
    Sci Rep; 2024 Jun; 14(1):14079. PubMed ID: 38890341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity maturation of a portable Fab-RNA module for chaperone-assisted RNA crystallography.
    Koirala D; Shelke SA; Dupont M; Ruiz S; DasGupta S; Bailey LJ; Benner SA; Piccirilli JA
    Nucleic Acids Res; 2018 Mar; 46(5):2624-2635. PubMed ID: 29309709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polar ring endows improved specificity to an antibody fragment.
    Schaefer ZP; Bailey LJ; Kossiakoff AA
    Protein Sci; 2016 Jul; 25(7):1290-8. PubMed ID: 27334407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody.
    Kaufmann B; Nybakken GE; Chipman PR; Zhang W; Diamond MS; Fremont DH; Kuhn RJ; Rossmann MG
    Proc Natl Acad Sci U S A; 2006 Aug; 103(33):12400-4. PubMed ID: 16895988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of the crystallizability and expression of an RNA crystallization chaperone.
    Ravindran PP; Héroux A; Ye JD
    J Biochem; 2011 Nov; 150(5):535-43. PubMed ID: 21785128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold.
    Lee CV; Liang WC; Dennis MS; Eigenbrot C; Sidhu SS; Fuh G
    J Mol Biol; 2004 Jul; 340(5):1073-93. PubMed ID: 15236968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications for an engineered Protein-G variant with a pH controllable affinity to antibody fragments.
    Bailey LJ; Sheehy KM; Hoey RJ; Schaefer ZP; Ura M; Kossiakoff AA
    J Immunol Methods; 2014 Dec; 415():24-30. PubMed ID: 25450256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the complex of an Fab fragment of a neutralizing antibody with foot-and-mouth disease virus: positioning of a highly mobile antigenic loop.
    Hewat EA; Verdaguer N; Fita I; Blakemore W; Brookes S; King A; Newman J; Domingo E; Mateu MG; Stuart DI
    EMBO J; 1997 Apr; 16(7):1492-500. PubMed ID: 9130694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of scFv peptide-binding specificity for crystal chaperone development.
    Pai JC; Culver JA; Drury JE; Motani RS; Lieberman RL; Maynard JA
    Protein Eng Des Sel; 2011 May; 24(5):419-28. PubMed ID: 21217145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.